Earnings Feed
Start Free
Home/Filings/4/0000911916-15-000160
4//SEC Filing

CoLucid Pharmaceuticals, Inc. 4

Accession 0000911916-15-000160

CIK 0001348649operating
View on SEC.govCompany Profile

Filed

May 6, 8:00 PM ET

Accepted

May 7, 12:40 PM ET

Size

22.6 KB

Accession

0000911916-15-000160

Insider Transaction Report

Form 4
Period: 2015-05-05
CoLucid Pharmaceuticals, Inc.CLCD
Markham Richard J
Director10% Owner
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+16,041→ 16,041 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (16,041 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+320,295→ 320,295 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (320,295 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+5,353→ 5,353 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (5,353 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-05-05+5,954→ 5,954 total
    Exercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying)
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+959,872→ 959,872 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (959,872 underlying)
Care Capital III LLC
10% Owner
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+959,872→ 959,872 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (959,872 underlying)
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+16,041→ 16,041 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (16,041 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+320,295→ 320,295 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (320,295 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+5,353→ 5,353 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (5,353 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-05-05+5,954→ 5,954 total
    Exercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying)
Care Capital Investments III L.P.
10% Owner
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+959,872→ 959,872 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (959,872 underlying)
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+16,041→ 16,041 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (16,041 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+320,295→ 320,295 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (320,295 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+5,353→ 5,353 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (5,353 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-05-05+5,954→ 5,954 total
    Exercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying)
Care Capital Offshore Investments III LP
10% Owner
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+959,872→ 959,872 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (959,872 underlying)
  • Purchase

    Series B Convertible Preferred Stock

    2015-01-12+16,041→ 16,041 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (16,041 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+320,295→ 320,295 total(indirect: By Care Capital Investments III, LP)
    → Common Stock (320,295 underlying)
  • Purchase

    Series C Convertible Preferred Stock

    2015-01-12+5,353→ 5,353 total(indirect: By Care Capital Offshore Investments III, LP)
    → Common Stock (5,353 underlying)
  • Award

    Stock Option (Right to Buy)

    2015-05-05+5,954→ 5,954 total
    Exercise: $10.00Exp: 2025-05-05→ Common Stock (5,954 underlying)
Footnotes (7)
  • [F1]Each share of Series B and Series C Convertible Preferred Stock is convertible at any time at the option of the holder, and will convert automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
  • [F2]Represents shares acquired on January 12, 2015 and reflects the 1-for-40.7 reverse stock split effected on April 17, 2015. These shares were also reported on the Form 3 filed on behalf of the reporting person on May 5, 2015.
  • [F3]The securities do not have an expiration date. The securities convert automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
  • [F4]Care Capital III LLC is the general partner of Care Capital Investments III LP and Care Capital Offshore Investments III LP and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Richard Markham, Jan Leschly, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons, each of whom disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
  • [F5]Represents securities held directly by Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F6]Represents securities held directly by Care Capital Offshore Investments III, LP, an affiliate of Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F7]Options fully vest immediately prior to the start of the Issuer's first annual meeting of stockholders following May 5, 2015.

Documents

1 file

Issuer

CoLucid Pharmaceuticals, Inc.

CIK 0001348649

→
Entity typeoperating

Related Parties

1
  • filerCIK 0001348649

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 12:40 PM ET
Size
22.6 KB
View on SEC.gov